Back
Apellis Pharmaceuticals Stock Predictions
Sponsored
APLS
Sponsored
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
33
APLS
Apellis Pharmaceuticals
Last Price:
26.19
Seasonality Move:
20.78%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Apellis Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 19% based on the past 6 years of stock performance.
- Apellis Pharmaceuticals has risen higher in 5 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 83.33%
-
Is Apellis Pharmaceuticals Stock Undervalued?
The current Apellis Pharmaceuticals [APLS] share price is $26.27. The Score for APLS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal. - APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Apellis Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 19% based on the past 6 years of stock performance.
Apellis Pharmaceuticals Stock Rating
Sell
33
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals overpriced?
- Apellis Pharmaceuticals has risen higher in 5 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 83.33%
Apellis Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com
52-Week Data
52-Week High:
73.80
52-Week Low:
24.34
Prediction Charts
Market Cap:
3.27B
Price in USD:
26.27
Volume:
5.5M
Beta:
0.84
Technical Analysis
SMA50:
30.19
SMA100:
34.08
SMA200:
43.29
52-Wk Change:
-45.72%
Stock Predictions
-
Is Apellis Pharmaceuticals stock public?
Yes, Apellis Pharmaceuticals is a publicly traded company. -
What is the Apellis Pharmaceuticals stock quote today?
The Apellis Pharmaceuticals stock price is 26.27 USD today. -
How to buy Apellis Pharmaceuticals stock online?
You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-29 | 27.42 | 27.41 | 28.09 | 26.95 |
Oct-30 | 26.86 | 27.71 | 28.06 | 26.80 |
Oct-31 | 27.55 | 27.25 | 28.17 | 27.21 |
Nov-1 | 27.31 | 27.98 | 28.11 | 27.11 |
Nov-4 | 27.58 | 28.52 | 30.13 | 27.47 |
Nov-5 | 25.40 | 28.08 | 28.33 | 24.34 |
Nov-6 | 29.93 | 28.87 | 29.99 | 27.27 |
Nov-7 | 28.67 | 28.74 | 29.05 | 27.73 |
Nov-8 | 28.68 | 30.02 | 30.14 | 28.51 |
Nov-11 | 30.11 | 29.58 | 30.46 | 29.56 |
Nov-12 | 29.25 | 29.26 | 29.61 | 28.79 |
Nov-13 | 29.40 | 28.23 | 29.94 | 28.23 |
Nov-14 | 28.44 | 28.06 | 28.87 | 27.81 |
Nov-15 | 28.05 | 26.27 | 28.05 | 26.02 |
Apellis Pharmaceuticals Earnings
Apellis Pharmaceuticals Earnings Report: Per Share Apellis Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apellis Pharmaceuticals Forecast Revenue Growth
Apellis Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.